Marker Therapeutics Inc (MRKR)

[microcapbiotech]

The trial data for both AML and Pancreatic seems to be good (or better) as far ad I know.
I think the botched report where parts of it (not the good parts)that were leaked early, did not help at all, but I also think that there is more going on other than that.
There is simply no interest in MRKR (other than us owners), no one cares or is looking at it.
With no interest, there is no steady volume, price ain't going to do nothing. When the short term holders sell on any upswing, then down goes the price again.
It is what it is. I'm holding.